Hypersensitivity to dinoprostone or prostaglandins. History of caesarean section or major uterine surgery; cephalopelvic disproportion, foetal malpresentation is present; pre-existing foetal distress; history of difficult labour &/or traumatic delivery; unexplained vag discharge & bleeding &/or abnormal uterine bleeding; evidence of placenta praevia. Patients w/ pelvic inflammatory disease; active cardiac, pulmonary, renal or hepatic disease.
Asthma or history of asthma, epilepsy or history of epilepsy, glaucoma or raised IOP, compromised CV, hepatic or renal function, HTN, ruptured chorioamniotic membranes; known history of hypertonic uterine contractility or tetanic uterine contractions; patients w/ multiple pregnancy. Monitor uterine activity, fetal heart rate & cervical dilation during therapy. Evaluate cephalopelvic relationships prior to use. Women ≥35 yr & w/ gestational age >40 wk. Not to be used during pregnancy.
G02AD02 - dinoprostone ; Belongs to the class of prostaglandins. Used to induce abortion or augment labour and to minimize blood loss from the placental site.
Sign Out
